APA (7th ed.) Citation

Owen, C., Bai, X., Quah, T., Lo, S., Allayous, C., Callaghan, S., . . . Michielin, O. (2021). Delayed immune-related adverse events with anti-PD-1-based immunotherapy in melanoma. Annals of Oncology, 32(7), 917. https://doi.org/10.1016/j.annonc.2021.03.204

Chicago Style (17th ed.) Citation

Owen, C.N, et al. "Delayed Immune-related Adverse Events with Anti-PD-1-based Immunotherapy in Melanoma." Annals of Oncology 32, no. 7 (2021): 917. https://doi.org/10.1016/j.annonc.2021.03.204.

MLA (9th ed.) Citation

Owen, C.N, et al. "Delayed Immune-related Adverse Events with Anti-PD-1-based Immunotherapy in Melanoma." Annals of Oncology, vol. 32, no. 7, 2021, p. 917, https://doi.org/10.1016/j.annonc.2021.03.204.